The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study

BackgroundFor esophageal squamous cell carcinoma(ESCC), neoadjuvant chemoimmunotherapy (nICT) constitutes an innovative therapeutic strategy. However, The relationship between its short-term efficacy and long-term prognosis requires further clarification. Therefore, this study aims to evaluate the p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuhan Xie, Shijie Huang, Zilu Tang, Hai Zhang, Jinxin Xu, Sunkui Ke, Jinbiao Xie, Rongyu Xu, Ying Chen, Zhinuan Hong, Mingqiang Kang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	neoadjuvant chemoimmunotherapy major pathological response adjuvant therapy pathological complete response recurrence pattern
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599526/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis
by: Hui Xu, et al.
Published: (2025-03-01)

CT-based habitat radiomics for predicting treatment response to neoadjuvant chemoimmunotherapy in esophageal cancer patients
by: Weibo Kong, et al.
Published: (2024-12-01)

MRI-based texture analysis for the evaluation of the response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma
by: Haoran Wei, et al.
Published: (2025-07-01)

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer
by: Xuwei Chen, et al.
Published: (2025-05-01)

Factors influencing pathological complete response following neoadjuvant chemoimmunotherapy in locally advanced microsatellite stable colorectal cancer: a retrospective analysis
by: Mingxiang Liu, et al.
Published: (2025-06-01)

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series
by: Lingyu Tan, et al.
Published: (2025-01-01)

Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non–small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes
by: Xingbiao Liu, et al.
Published: (2025-03-01)

Evaluation of ctDNA-guided adjuvant therapy de-escalation in head and neck squamous cell carcinoma: a comparative cohort study
by: Xu Zhang, et al.
Published: (2025-08-01)

Application of machine learning based on habitat imaging and vision transformer to predict treatment response of locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a multi-center study
by: Shu-Han Xie, et al.
Published: (2025-08-01)

Real-world comparison of neoadjuvant chemoimmunotherapy and chemotherapy in muscle-invasive bladder cancer
by: Xinjia Ding, et al.
Published: (2025-05-01)

Pathologic complete response after neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Endoscopic characteristics and implications
by: Peng Yuan, et al.
Published: (2025-01-01)

Prognostic Significance, Radiological, and Metabolic Characteristics of Metastatic Lymph Nodes in Resectable Non‐Small Cell Lung Cancer Following Neoadjuvant Chemoimmunotherapy
by: Tianxiao Han, et al.
Published: (2025-05-01)

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study
by: Ying Liu, et al.
Published: (2023-12-01)

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma
by: Peipei Zhang, et al.
Published: (2024-11-01)

ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
by: Chao He, et al.
Published: (2025-04-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
by: Hao Cui, et al.
Published: (2025-07-01)

Recurrence patterns and long-term survival of locally advanced esophageal cancer patients with pathological complete response after different neoadjuvant therapies followed by surgery
by: Jiwei Wu, et al.
Published: (2025-07-01)

Construction of a nomogram prediction model for the pathological complete response after neoadjuvant chemotherapy in breast cancer: a study based on ultrasound and clinicopathological features
by: Pingjuan Ni, et al.
Published: (2025-03-01)

Intra- and peritumoral radiomics nomogram based on DCE-MRI for the early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
by: Yun Zhu, et al.
Published: (2025-06-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

Effect of HER2-low expression on the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
by: Lin-Yu Xia, et al.
Published: (2025-06-01)

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
by: Canjun Li, et al.
Published: (2025-04-01)

Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
by: Tan Q, et al.
Published: (2025-05-01)

Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world study
by: Song Guan, et al.
Published: (2025-07-01)

Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After Neoadjuvant Chemotherapy in Breast Cancer
by: Mingxi Zhu, et al.
Published: (2025-02-01)

Pathologic response rates in HER2-low versus HER2-zero early breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis
by: Francisco Cezar Aquino de Moraes, et al.
Published: (2025-03-01)

Neoadjuvant Chemo-Endocrine Therapy for Hormone Receptor Positive Breast Cancer: A Meta-Analysis
by: Zhen-Yu Li, et al.
Published: (2023-04-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
by: P. V. Krivorotko, et al.
Published: (2022-12-01)

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma
by: Gaofeng Ding, et al.
Published: (2025-05-01)

Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node‐Positive Breast Cancer: Real World Data
by: Danyang Ji, et al.
Published: (2025-04-01)

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis
by: Menghao Dong, et al.
Published: (2025-05-01)

High pathological tumor response associates with enhanced overall survival in HNSCC patients following neoadjuvant immunochemotherapy and surgery
by: Yudong Ning, et al.
Published: (2025-05-01)

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
by: Kaishang Zhang, et al.
Published: (2025-07-01)

FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
by: Emine Yıldırım, et al.
Published: (2022-01-01)

Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer
by: Yuwen Liang, et al.
Published: (2025-06-01)

The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer
by: Jonas Busk Holm, et al.
Published: (2025-07-01)

Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Liangjing Zhou, et al.
Published: (2025-07-01)